Bigtec Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Temasek and MOPE-backed Molbio Diagnostics kickstarts IPO prep, aims Rs 22,000-24,000 cr valuation
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
Truenat diagnostic tests will be available for 30 more diseases in next 2 years
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Synopsis
Motilal Oswal PE has about 13.5% stake, acquiring it through two tranches of primary and secondary deals at a valuation of about ₹1,600-₹2,200 crore about a year ago. A few minority shareholders hold the rest.
PTI
The Singapore government’s investment fund Temasek Holdings is in advanced talks to acquire about 15% stake in Covid-19 test kits maker Molbio Diagnostics for ₹1,500-₹1,800 crore ($250 million), multiple people aware of the development said.
Molbio is likely to be valued at ₹12,000 crore ($1.6 billion) after the proposed funding round, wherein a couple of promoters will sell around 15% in the Goa-based company, which develops and commercialises the point-of-care molecular diagnostics platform TrueNat.